ArticleCancer gene therapy2022
Bioreductive prodrug PR-104 improves the tumour distribution and titre of the nitroreductase-armed oncolytic adenovirus ONYX-411
Dean C Singleton et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it